Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

More articles from Original Article

  • Open Access
    IL-33/ST2 signalling promotes tumor growth by regulating polarization of alternatively activated macrophages
    Liping Liu, Haoge Luo, Yingdong Xie, Ying Wang, Shiying Ren, Haiyang Sun and Dong Li
    Cancer Biology & Medicine April 2025, 22 (4) 376-395; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0483
  • Open Access
    Neoepitope BTLAP267L-specific TCR-T cell immunotherapy unlocks precision treatment for hepatocellular carcinoma
    Fang Liu, Hua Chen, Suxin Wu, Chenlu Zhu, Mingji Zhang, Wei Rui, Dong Zhou, Yang Wang, Xin Lin, Xueqiang Zhao and Yunbin Ye
    Cancer Biology & Medicine April 2025, 22 (4) 412-432; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0434
  • Open Access
    Optimal immunotherapy duration in advanced NSCLC: defining the ideal treatment window
    Kaibo Ding, Dujiang Liu, Xinyue Li, Zhongsheng Peng, Lin Zhu and Yanjun Xu
    Cancer Biology & Medicine March 2025, 22 (3) 284-294; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0457
  • Open Access
    Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma
    Yi Wang, Yuting Yan, Dandan Shan, Jiawen Chen, Wei Liu, Tingyu Wang, Gang An, Weiwei Sui, Wenyang Huang, Wenjie Xiong, Huimin Liu, Qi Sun, Huijun Wang, Zhijian Xiao, Jianxiang Wang, Lugui Qiu, Dehui Zou and Shuhua Yi
    Cancer Biology & Medicine February 2025, 22 (2) 177-189; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0200
  • Open Access
    Erianin inhibits the proliferation of lung cancer cells by suppressing mTOR activation and disrupting pyrimidine metabolism
    Lili Yan, Yanfen Liu, Yufei Huang, Xiaoyu Sun, Haiyang Jiang, Jie Gu, Jing Xia, Xueni Sun and Xinbing Sui
    Cancer Biology & Medicine February 2025, 22 (2) 144-165; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0385
  • Open Access
    Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment: a prospective study of clinical functional MR-based modeling
    Wenhua Li, Huan Zhang, Zhe Gong, Yue Li, Zhiyu Chen, Xiaodong Zhu, Mingzhu Huang, Zhe Zhang, Chenchen Wang, Lixin Qiu, Qirong Geng, Jinjia Chang, Xiaoying Zhao, Xuedan Sheng, Wen Zhang, Tong Tong and Weijian Guo
    Cancer Biology & Medicine February 2025, 22 (2) 166-176; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0389
  • Open Access
    Safety and efficacy of intraoperative radiation therapy using a low-energy X-ray source for resectable pancreatic cancer: an interim evaluation of an ongoing prospective phase II study
    Xingyun Chen, Shuo Li, Chuntao Gao, Wei Wang, Haorui Li, Yuxiao Liu, Rui Liu and Jihui Hao
    Cancer Biology & Medicine January 2025, 22 (1) 67-76; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0287
  • Open Access
    Carnitine palmitoyltransferase 1C promotes EMT-associated cisplatin resistance in non-small cell lung cancer cells
    Renjie Chen, Jiahui Wang, Shuoyu Huang, Xuefeng Hu, Xinran He, Tiange Zhang, Yunhan Hu, Huijun Wei, Sihui Nian, Yushu Huang and Zhihao Wu
    Cancer Biology & Medicine January 2025, 22 (1) 48-66; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0459
  • Open Access
    Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centers
    Zhihao Lu, Mingfei Geng, Yongtao Han, Jianzhong Cao, Jun Wang, Tianshu Liu, Xianglin Yuan, Xue Meng, Yanqiao Zhang, Rong Zhao, Lixin Wan, Enxiao Li, Wenran Wang, Zhijie Li, Danfeng Shi, Jing Qian, Si Shi, Fengshi Dong and Lin Shen
    Cancer Biology & Medicine December 2024, 21 (12) 1171-1184; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0336
  • Open Access
    Osimertinib exacerbates immune checkpoint inhibitor-related severe adverse events by activating the IL-6/JAK/STAT3 pathway in macrophages
    Yuan Li, Yanping Chen, Yuan Meng, Meng Shen, Fan Yang and Xiubao Ren
    Cancer Biology & Medicine December 2024, 21 (12) 1156-1170; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0269

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 45

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire